Literature DB >> 16013087

A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging.

Ali S Arbab1, Lindsey B Wilson, Parwana Ashari, Elaine K Jordan, Bobbi K Lewis, Joseph A Frank.   

Abstract

Ferumoxides, dextran-coated superparamagnetic iron oxide (SPIO) particles, form ferumoxide-transfection agent (FE-TA) complexes that are internalized into endosomes/lysosomes and have been used to label cells for in vivo MRI tracking and localization studies. A better understanding of the physical state of the FE-TA complexes during endocytosis could improve their use. The purpose of this study was to measure the rate of the degradation of iron particles under varying physiological conditions. FE-TA complexes were incubated in seven different buffers containing different chelates with different pH. Reducible iron concentrations, T2 relaxation rates and gradient echo (GRE) magnetic resonance images (MRI) were obtained from each condition immediately after incubation and at 6, 24, 48, 72 and 96 h and days 7, 14 and 21. The dynamics of FE-TA in the endosome/lysosomes within the cells were visualized with electron microscopy. Sodium citrate buffer at pH 4.5 rapidly dissolved FE-TA complexes. However, FE-TA complexes were less soluble in the same buffer at pH 5.5. Similarly, FE-TA complexes were not readily soluble in any of the other buffers with or without chelates, regardless of pH. Electron microscopic images showed degraded FE-TA in some intracellular endosome/lysosomes between days 3 and 5. In the cellular environment, some of the FE-TA-containing endosomes were found to fuse with lysosomes, causing rapid dissociation at low pH and exposing the iron core to chelates that resulted in soluble Fe(III) within the lysosomes. The studies presented represent a first step in identifying the important cellular environmental parameters affecting the integrity of FE-TA complexes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16013087     DOI: 10.1002/nbm.970

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  94 in total

Review 1.  Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications.

Authors:  Paul Galvin; Damien Thompson; Katie B Ryan; Anna McCarthy; Anne C Moore; Conor S Burke; Maya Dyson; Brian D Maccraith; Yurii K Gun'ko; Michelle T Byrne; Yuri Volkov; Chris Keely; Enda Keehan; Michael Howe; Conor Duffy; Ronan MacLoughlin
Journal:  Cell Mol Life Sci       Date:  2011-10-21       Impact factor: 9.261

2.  Ferritin enhances SPIO tracking of C6 rat glioma cells by MRI.

Authors:  Jiandong Wang; Jin Xie; Xiaojun Zhou; Zhen Cheng; Ning Gu; Gaojun Teng; Qiujue Hu; Feipeng Zhu; Shuanghui Chang; Fan Zhang; Guangming Lu; Xiaoyuan Chen
Journal:  Mol Imaging Biol       Date:  2011-02       Impact factor: 3.488

3.  Gene expression profiling reveals early cellular responses to intracellular magnetic labeling with superparamagnetic iron oxide nanoparticles.

Authors:  Dorota A Kedziorek; Naser Muja; Piotr Walczak; Jesus Ruiz-Cabello; Assaf A Gilad; Chunfa C Jie; Jeff W M Bulte
Journal:  Magn Reson Med       Date:  2010-04       Impact factor: 4.668

4.  Phase contrast MRI is an early marker of micrometastatic breast cancer development in the rat brain.

Authors:  Matthew D Budde; Eric Gold; E Kay Jordan; Melissa Smith-Brown; Joseph A Frank
Journal:  NMR Biomed       Date:  2011-09-22       Impact factor: 4.044

Review 5.  Imaging stem cells implanted in infarcted myocardium.

Authors:  Rong Zhou; Paul D Acton; Victor A Ferrari
Journal:  J Am Coll Cardiol       Date:  2006-11-01       Impact factor: 24.094

6.  Biocompatible and pH-sensitive PLGA encapsulated MnO nanocrystals for molecular and cellular MRI.

Authors:  Margaret F Bennewitz; Tricia L Lobo; Michael K Nkansah; Gözde Ulas; Gary W Brudvig; Erik M Shapiro
Journal:  ACS Nano       Date:  2011-05-03       Impact factor: 15.881

7.  Fluorophore-conjugated iron oxide nanoparticle labeling and analysis of engrafting human hematopoietic stem cells.

Authors:  Dustin J Maxwell; Jesper Bonde; David A Hess; Sarah A Hohm; Ryan Lahey; Ping Zhou; Michael H Creer; David Piwnica-Worms; Jan A Nolta
Journal:  Stem Cells       Date:  2007-11-29       Impact factor: 6.277

8.  Effects of supermagnetic iron oxide labeling on the major functional properties of human mesenchymal stem cells from multiple sclerosis patients.

Authors:  Ibrahim Kassis; Adi Vaknin-Dembinsky; Jeff Bulte; Dimitrios Karussis
Journal:  Int J Stem Cells       Date:  2010-05       Impact factor: 2.500

9.  Dextran coated bismuth-iron oxide nanohybrid contrast agents for computed tomography and magnetic resonance imaging.

Authors:  Pratap C Naha; Ajlan Al Zaki; Elizabeth Hecht; Michael Chorny; Peter Chhour; Eric Blankemeyer; Douglas M Yates; Walter R T Witschey; Harold I Litt; Andrew Tsourkas; David P Cormode
Journal:  J Mater Chem B       Date:  2014-12-14       Impact factor: 6.331

10.  Convertible manganese contrast for molecular and cellular MRI.

Authors:  Erik M Shapiro; Alan P Koretsky
Journal:  Magn Reson Med       Date:  2008-08       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.